Mayo Clinic Laboratory and Pathology Research Roundup: September 7
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
99th Percentile Upper-Reference Limit of Cardiac Troponin and the Diagnosis of Acute Myocardial Infarction.
The 99th percentile of cTn remains the best-established criterion for the diagnosis of acute MI. While not perfect, it is analytically and clinically evidence-based. Until there are robust data to suggest some other approach, staying with the 99th percentile, a threshold that has served the field well for the past 20 years, appears prudent. Via Clinical Chemisty.
Published to PubMed This Week
- Sensitivity-specificity of tau and Aβ PET in frontotemporal lobar degeneration.
Annals of Neurology - Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.
Mayo Clinic Proceedings - Sex and Gender Disparities in the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Older Adults.
Mayo Clinic Proceedings - Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples.
Mayo Clinic Proceedings - Mucinous Carcinoma of the Breast.
Mayo Clinic Proceedings - Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens.
Mayo Clinic Proceedings - Prevalence of opioid induced adrenal insufficiency in patients taking chronic opioids.
Journal of Clinical Endocrinology and Metabolism - Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas.
American Journal of Clinical Pathology - Assessing Utilization of the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Diagnosis of Neurosyphilis: a Cohort Study.
Journal of Genetic Internal Medicine - Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ.
Surgery
